ACA
TECH icon

American Capital Advisory’s Bio-Techne TECH Stock Holding History

American Capital Advisory’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Sell
155
-1
-0.6% -$54 ﹤0.01% 353
2026
Q1 		$8.15K Buy
156
+9
+6% +$540 ﹤0.01% 358
2025
Q4 		$8.65K Hold
147
– – ﹤0.01% 337
2025
Q3 		$8.18K Hold
147
– – ﹤0.01% 323
2025
Q2 		$7.56K Buy
+147
New +$7.39K ﹤0.01% 310

Other funds holding TECH

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

American Capital Advisory's TECH Position: Q2 2026 in Review

American Capital Advisory reduced its Bio-Techne (TECH) stake by 0.64% in Q2 2026, selling an estimated $54 and leaving 155 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #353.

American Capital Advisory first reported a position in TECH in Q2 2025 and has held it in 5 quarters since. 179 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • American Capital Advisory held 155 shares of Bio-Techne worth $11K as of Q2 2026.
  • American Capital Advisory sold 1 Bio-Techne share in Q2 2026, an estimated $54.
  • Bio-Techne made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #353 holding.
  • American Capital Advisory first reported a position in Bio-Techne in Q2 2025 and has held it in 5 quarters since.
  • 179 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.